CADUET TABLETS 10MG/80MG Singapore - English - HSA (Health Sciences Authority)

caduet tablets 10mg/80mg

pfizer private limited - amlodipine besylate eqv to amlodipine (extra-granular ingredients) - tablet, film coated - 10 mg

CADUET TABLETS 5MG20MG Singapore - English - HSA (Health Sciences Authority)

caduet tablets 5mg20mg

viatris private limited - amlodipine besylate eqv amlodipine (extra-granular ingredients); atorvastatin calcium eqv atorvastatin (atorvastatin granulation) - tablet, film coated - 5 mg - amlodipine besylate eqv amlodipine (extra-granular ingredients) 5 mg; atorvastatin calcium eqv atorvastatin (atorvastatin granulation) 20 mg

CADUET- amlodipine besylate and atorvastatin calcium tablet, film coated
CADUET- amlodipine and atorvastatin tablet, film coate United States - English - NLM (National Library of Medicine)

caduet- amlodipine besylate and atorvastatin calcium tablet, film coated caduet- amlodipine and atorvastatin tablet, film coate

pfizer laboratories div pfizer inc - amlodipine besylate (unii: 864v2q084h) (amlodipine - unii:1j444qc288), atorvastatin calcium trihydrate (unii: 48a5m73z4q) (atorvastatin - unii:a0jwa85v8f) - amlodipine 2.5 mg - caduet (amlodipine and atorvastatin) is indicated in patients for whom treatment with both amlodipine and atorvastatin is appropriate. amlodipine amlodipine is indicated for the treatment of hypertension, to lower blood pressure. lowering blood pressure reduces the risk of fatal and nonfatal cardiovascular events, primarily strokes and myocardial infarctions. these benefits have been seen in controlled trials of antihypertensive drugs from a wide variety of pharmacologic classes including amlodipine. control of high blood pressure should be part of comprehensive cardiovascular risk management, including, as appropriate, lipid control, diabetes management, antithrombotic therapy, smoking cessation, exercise, and limited sodium intake. many patients will require more than one drug to achieve blood pressure goals. for specific advice on goals and management, see published guidelines, such as those of the national high blood pressure education program's joint national committee on prevention, detection, evaluatio

Caduet 10 mg, 5 mg Jordan - English - JFDA (Jordan Food & Drug Administration - المؤسسة العامة للغذاء والدواء)

caduet 10 mg, 5 mg

مستودع ادوية الصباغ - sabbagh drug store - atorvastatin 10 mg, amlodipine 5 mg - 10 mg, 5 mg

Caduet 10 mg, 10 mg Jordan - English - JFDA (Jordan Food & Drug Administration - المؤسسة العامة للغذاء والدواء)

caduet 10 mg, 10 mg

مستودع ادوية الصباغ - sabbagh drug store - atorvastatin 10 mg, amlodipine 10 mg - 10 mg, 10 mg

Caduet 10/10mg Malta - English - Medicines Authority

caduet 10/10mg

pfizer hellas s.a. - amlodipine, atorvastatin - film-coated tablet - amlodipine 10 milligram(s) ; atorvastatin 10 milligram(s) - lipid modifying agents

CADUET- amlodipine besylate and atorvastatin calcium tablet, film coated United States - English - NLM (National Library of Medicine)

caduet- amlodipine besylate and atorvastatin calcium tablet, film coated

physicians total care, inc. - amlodipine besylate (unii: 864v2q084h) (amlodipine - unii:1j444qc288), atorvastatin calcium (unii: 48a5m73z4q) (atorvastatin - unii:a0jwa85v8f) - amlodipine besylate 2.5 mg - caduet (amlodipine and atorvastatin) is indicated in patients for whom treatment with both amlodipine and atorvastatin is appropriate. and therapy with lipid-altering agents should be only one component of multiple risk factor intervention in individuals at significantly increased risk for atherosclerotic vascular disease due to hypercholesterolemia. drug therapy is recommended as an adjunct to diet when the response to a diet restricted in saturated fat and cholesterol and other nonpharmacologic measures alone has been inadequate. in patients with chd or multiple risk factors for chd, the atorvastatin component of caduet can be started simultaneously with diet restriction. - reduce the risk of myocardial infarction - reduce the risk of stroke - reduce the risk for revascularization procedures and angina - reduce the risk of myocardial infarction - reduce the risk of stroke; - reduce the risk of non-fatal myocardial infarction - reduce the risk of fatal and non-fatal stroke - reduce the risk for revas

CADUET ® 10/40 Israel - English - Ministry of Health

caduet ® 10/40

pfizer pharmaceuticals israel ltd - amlodipine as besylate 10 mg; atorvastatin as calcium 40 mg - film coated tablets - amlodipine - caduet (amlodipine and atorvastatin ) is indicated in patients for whom treatment with both amlodipine and atorvastatin is apptopriate. amlodipine: - hypertension - chronic stable angina - vasospastic angina (prinzmetal's or variant angina). atorvastatin : - prevention of cardiovascular disease - heterozygous familial and nonfamilial hypercholesterolemia - elevated serum tg levels - primary dysbetalipoproteinemia - homozygous familial hypercholesterolemia - pediatric patients (10-17 years of age) : atorvastatin is indicated as an adjunct to diet to reduce total -c ldl-c and apo b levels in boys and postmenarchal girls 10 to 17 years of age with heterozygous familial hypercholesterolemia if after an adequate trial of diet therapy the following findings are present: 1. ldl-c remains >or = 190 mg/dl or 2. ldl-c remains > or = 160 mg/dl and: there is a positive family history of premature cardiovascular disease or two or more other cvd risk factors are present in the pediatric patient.

CADUET TABLETS 5MG/80MG Singapore - English - HSA (Health Sciences Authority)

caduet tablets 5mg/80mg

pfizer private limited - amlodipine besylate eqv to amlodipine (extra-granular ingredients) - tablet, film coated - 5 mg

Caduet 40 mg, 5 mg Jordan - English - JFDA (Jordan Food & Drug Administration - المؤسسة العامة للغذاء والدواء)

caduet 40 mg, 5 mg

مستودع ادوية الصباغ - sabbagh drug store - atorvastatin 40 mg, amlodipine 5 mg - 40 mg, 5 mg